|
|
Betty P. Tsao, Rita M. Cantor, Jennifer M. Grossman, Nan Shen, Nickolay T. Teophilov, Daniel J. Wallace, Frank C. Arnett, Klaus Hartung, Rose Goldstein, Kenneth C. Kalunian, Bevra H. Hahn, Jerome I. Rotter
J Clin Invest. 1999;
103(8):1135
doi:10.1172/JCI5967
Abstract |
Full text
| PDF

S
ystemic lupus erythematosus (SLE) is an autoimmune disease characterized by various autoantibodies that recognize autoantigens displayed on the surface of cells undergoing apoptosis. The genetic contribution to SLE susceptibility has been widely recognized. We previously reported evidence for linkage to SLE of the human chromosome 1q41–q42 region and have now narrowed it from 15 to 5 cM in an extended sample using multipoint linkage analysis. Candidate genes within this region include (a) PARP, poly(ADP-ribose) polymerase, encoding a zinc-finger DNA-binding protein that is involved in DNA repair and apoptosis; (b) TGFB2, encoding a transforming growth factor that regulates cellular interactions and responses; and (c) HLX1, encoding a homeobox protein that may regulate T-cell development. Using a multiallelic, transmission-disequilibrium test (TDT), we found overall skewing of transmission of PARP alleles to affected offspring in 124 families (P = 0.00008), preferential transmission of a PARP allele to affected offspring (P = 0.0003), and lack of transmission to unaffected offspring (P = 0.004). Similar TDT analyses of TGFB2 and HLX1 polymorphisms yielded no evidence for association with SLE. These results suggest that PARP may be (or is close to) the susceptibility gene within the chromosome 1q41–q42 region linked to SLE.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(51)
| Title and authors |
Publication |
Year |
Biomarkers for systemic lupus erythematosus
Joseph M. Ahearn, Chau-Ching Liu, Amy H. Kao, Susan Manzi
|
Translational Research
|
2012 |
Endogenous retroviral pathogenesis in lupus
Andras Perl, David Fernandez, Tiffany Telarico, Paul E Phillips
|
Current Opinion in Rheumatology
|
2010 |
Pathogenic mechanisms in systemic lupus erythematosus
Andras Perl
|
Autoimmunity
|
2010 |
Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and systemic sclerosis
Barbara Cerboni, Gabriella Morozzi, Mauro Galeazzi, Francesca Bellisai, Vanna Micheli, Giuseppe Pompucci, Silvia Sestini
|
Human Immunology
|
2009 |
Genetic studies of systemic lupus erythematosus in Asia: where are we now?
I Kim, Y J Kim, K Kim, C Kang, C-B Choi, Y-K Sung, H-S Lee, S-C Bae
|
Genes Immun
|
2009 |
Recent advances in physiological and pathological significance of NAD metabolites: roles of poly(ADP-ribose) and cyclic ADP-ribose in insulin secretion and diabetogenesis
Hiroshi Okamoto, Shin Takasawa
|
NRR
|
2009 |
The search for lupus biomarkers.
Chau-Ching Liu, Joseph M Ahearn
|
Best Pract Res Clin Rheumatol
|
2009 |
Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogrenʼs syndrome
Andras Perl
|
Current Opinion in Rheumatology
|
2009 |
Genetics of systemic lupus erythematosus
Andrea L Sestak
|
Future Rheumatology
|
2008 |
Ying-Yang (YY-1) Expression and Fas in Biopsies of Children With Type IV Lupus Nephritis Correlates With the Clinical Condition
Rubén Márquez-Marín, Berenice Sánchez Arellano, César González-Bonilla, Eunice Solís Vallejo, José Luis Matamoros-Tapia, Sara Huerta-Yepez
|
Reumatolog ía Cl ínica (English Edition)
|
2007 |
|